Tiverton Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,147	Closed	-$577K	–	713
2019 Q2	$577K	Sell	1,147 -393	-26%	-$277K	0.02%	351
2019 Q1	$1.53M	Sell	1,540 -1,499	-49%	-$1.39M	0.07%	195
2018 Q4	$2.64M	Sell	3,039 -1,087	-26%	-$1.01M	0.16%	110
2018 Q3	$4.26M	Buy	4,126 +633	+18%	+$619K	0.21%	94
2018 Q2	$3.21M	Sell	3,493 -16	-0.5%	-$17.2K	0.16%	109
2018 Q1	$3.42M	Buy	3,509 +2,831	+418%	+$2.58M	0.24%	94
2017 Q4	$306K	Sell	678 -449	-40%	-$166K	0.02%	304
2017 Q3	$466K	Sell	1,127 -138	-11%	-$52K	0.03%	166
2017 Q2	$443K	Sell	1,265 -427	-25%	-$165K	0.02%	172
2017 Q1	$869K	Hold	1,692	–	–	0.04%	167
2016 Q4	$600K	Sell	1,692 -1,527	-47%	-$647K	0.04%	179
2016 Q3	$1.72M	Sell	3,219 -4,936	-61%	-$2.68M	0.14%	133
2016 Q2	$6.75M	Buy	8,155 +1,351	+20%	+$648K	0.28%	97
2016 Q1	$3.24M	Sell	6,804 -601	-8%	-$271K	0.11%	124
2015 Q4	$4.89M	Hold	7,405	–	–	0.16%	112
2015 Q3	$5.82M	Sell	7,405 -1,600	-18%	-$1.95M	0.13%	115
2015 Q2	$11.9M	Buy	9,005 +1,405	+18%	+$1.61M	0.24%	100
2015 Q1	$7.9M	Buy	7,600 +3,600	+90%	+$2.38M	0.16%	112
2014 Q4	$2.67M	Buy	+4,000	New	+$2.44M	0.06%	127

Other funds holding ATRA